Sientra (SIEN) PT Raised to $29 at Leerink Partners

Leerink Partners analyst Richard Newitter reiterated an Outperform rating and bumped his price target on Sientra (NASDAQ: SIEN) to $29.00 (from $25.00) following solid 2Q, which saw a rev/EPS beat and another quarter of 20%+ growth.

Newitter commented, "This reinforces our confidence in the company's ability to continue gaining share in the US breast augmentation market and sustain above average top-line growth prospects with new products in key implant modalities and sales rep hires driving increased sales momentum in the quarters ahead. Reiterate OP, PT to $29 from $25 based on multiple expansion for the group."

For an analyst ratings summary and ratings history on Sientra click here. For more ratings news on Sientra click here.

Shares of Sientra closed at $24.39 yesterday.

You May Also Be Interested In

• Take-Two Interactive (TTWO) PT Raised to $368 at BofA Securities
• Alaska Air (ALK) PT Raised to $62 at UBS on Updated Q2 Estimates
• Taysha Gene Therapies (TSHA) PT Raised to $14 at BMO Capital on Differentiation